726 results found.
                    
Smith+Nephew Announces First JOURNEY II Unicompartmental Knee Procedures
Smith+Nephew announced limited launch of the new JOURNEY™ II Unicompartmental Knee.
Top 10 Takeaways from Orthopedics in 2019
 
Entry Into Joint Replacement a Major Step in Globus Medical’s Evolution
By Mike Evers In October, we sat down with leaders from Globus Medical to discuss their surprising entrance into the joint replacement market and robotics’ role in orthopedic surgery. As a quick refresher, during 2Q19 Globus Medical announced that it had acquired substantially all...
Enabling Technology and Integrated Selling Strategies Drove Orthopedic Growth in the Third Quarter
The third quarter of 2019 brought some standout performances from large players like Stryker, Medtronic, NuVasive and Globus Medical. DePuy Synthes and Zimmer Biomet made incremental progress in returning to market growth. Notably, the top performing players all have well-established enabling tec...
Stryker to Acquire Wright Medical, Bolster Extremities Portfolio
Stryker announced their intention to acquire Wright Medical, effectively boosting their extremities portfolio and making them the clear second-largest player in the orthopedic market by revenue, according to our estimates. Wright Medical is expected to be purchased for $30.75 per share,...
Smith+Nephew REGENTEN Bioinductive Implant Study Results
A prospective, non-comparative arm study of Smith+Nephew's REGENETEN™ in 23 U.S. patients with large and massive rotator cuff tears demonstrated a 96...
Smith+Nephew Launches OR30 Dual Mobility Hip
Smith+Nephew launched the OR3O™ Dual Mobility System for use in primary and revision hip replacement.
Conformis Continues Slide Due to Aetna Coverage Denials
Conformis reports 3Q19 revenue of USD $17.3MM, -40.3% vs. 3Q18.
Strength in Knee Replacement and Sports Medicine Drives Smith+Nephew Growth
Smith+Nephew reports 3Q19 orthopedic revenue of USD $852MM, +4.7% vs. 3Q18.
Smith+Nephew CEO Stepping Down
Smith+Nephew CEO Namal Nawana will step down from his position on October 31, by mutual agreement, to pursue opportunities outside of the U.K.
Smith & Nephew NOVOSTITCH Meniscal Repair Study Update
One-year results from a study of Smith & Nephew's NOVOSTITCH Meniscal Repair demonstrated a success rate of 91.7% and significant improvement in knee pain a...
Smith & Nephew Launches TRIGEN INTERTAN Fracture Nail Assurance Program
Smith & Nephew launched a product assurance program that will reimburse a healthcare facility for the cost of the TRIGEN™ INTERTAN™ ...
Smith & Nephew Launches LENS 4K Surgical Imaging System
Smith & Nephew launched LENS 4K Surgical Imaging for end-to-end 4K imaging.
Orthopedic Public Companies Grow 2.6% YoY in Quarter
By Mike Evers The second quarter of 2019 brought incremental improvement over the first. Year over year revenue grew 2.6% in the quarter for the public companies reported herein compared to 1.1% last quarter. The five largest orthopedic players, which control 58% of the market, showed a...
Smith & Nephew and VirtaMed to Partner on Surgical Simulation Training
Smith & Nephew is collaborating with VirtaMed on surgical simulation training for SNN's systems for arthroscopic repair.
Smith & Nephew Launches EVOS WRIST Plating
Smith & Nephew launched the EVOS WRIST Plating System to treat simple and complex wrist fractures.
Market Insight: Orthobiologic Products Must Become Procedure-Specific
By Andy Carter, Ph.D. Editor’s Note: Orthobiologics play a role in every orthopedic market segment; therefore, the importance of their advancements affects the industry as a whole. We asked Andy Carter, Ph.D., Chief Technology Officer at TheraCell, to give his insight on the ...
Smith & Nephew Up +1.6% in 2Q19 on Sports Medicine
Smith & Nephew reports 2Q19 orthopedic revenue of USD $892MM, +1.6% vs. 2Q18.
Globus Medical Acquires StelKast, Hip and Knee Device Company
Globus Medical (GMED) acquired StelKast, manufacturer of implants and instruments for hip and knee replacement, for USD $24.1MM in ca...
Orthopedic Funding Covers Breadth of Industry in 1H19
By Mike Evers and Julie A. Vetalice Funding activity in 1H19 spanned all market segments of the orthopedic industry fairly evenly. We tracked 19 announcements, with spine representing five of those; joint replacement, trauma, sports medicine and orthobiologics each representing three an...
Smith & Nephew NOVOSTITCH Study Results
Study results indicate that Smith & Nephew's NOVOSTITCH™ knee meniscal repair technology delivered a 0% re-operation rate and 100% meniscal healing at 6 months.
Orthopedic Market Forces to Watch: A Conversation with Ali Madani
By Carolyn LaWell In March, we attended the IMPLANTS Tutorials Session hosted by AVICENNE to gain additional perspective on the orthopedic device and contract manufacturing markets. Our market numbers, as well as thoughts on what’s driving the industry, were validated during the t...
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Robotics Recap: Orthopedic Executives Remain Bullish
By Mike Evers   Despite normal seasonal softness in capital sales, the first quarter of 2019 was an active one for robotic and digital surgery developments. New entrants into the orthopedic robot market like Zimmer Biomet’s ROSA Knee may lead to longer buying cycles as ...
Smith & Nephew Acquiring Optical Tracking Technology for CAS
Smith & Nephew agreed to acquire Atracsys, provider of optical tracking technology used in computer-assisted s...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group